Pallas Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Sell |
12,365
-980
| -7% | -$123K | 0.06% | 235 |
|
|
2025
Q1 | $1.83M | Buy |
13,345
+7,694
| +136% | +$1.05M | 0.08% | 195 |
|
|
2024
Q4 | $864K | Buy |
5,651
+3,095
| +121% | +$473K | 0.04% | 259 |
|
|
2024
Q3 | $470K | Sell |
2,556
-45
| -2% | -$8.27K | 0.02% | 375 |
|
|
2024
Q2 | $586K | Sell |
2,601
-58
| -2% | -$13.1K | 0.03% | 289 |
|
|
2024
Q1 | $573K | Buy |
+2,659
| New | +$573K | 0.02% | 266 |
|
|
2023
Q4 | – | Sell |
-2,677
| Closed | -$635K | – | 360 |
|
|
2023
Q3 | $635K | Sell |
2,677
-183
| -6% | -$43.4K | 0.04% | 211 |
|
|
2023
Q2 | $796K | Sell |
2,860
-192
| -6% | -$53.5K | 0.04% | 170 |
|
|
2023
Q1 | $894K | Sell |
3,052
-6
| -0.2% | -$1.76K | 0.08% | 154 |
|
|
2022
Q4 | $874K | Buy |
3,058
+4
| +0.1% | +$1.14K | 0.09% | 160 |
|
|
2022
Q3 | $856K | Sell |
3,054
-151
| -5% | -$42.3K | 0.1% | 141 |
|
|
2022
Q2 | $661K | Sell |
3,205
-75
| -2% | -$15.5K | 0.09% | 136 |
|
|
2022
Q1 | $697K | Sell |
3,280
-223
| -6% | -$47.4K | 0.09% | 137 |
|
|
2021
Q4 | $772K | Buy |
3,503
+136
| +4% | +$30K | 0.09% | 144 |
|
|
2021
Q3 | $941K | Buy |
3,367
+67
| +2% | +$18.7K | 0.1% | 151 |
|
|
2021
Q2 | $1.12M | Sell |
3,300
-79
| -2% | -$26.7K | 0.16% | 110 |
|
|
2021
Q1 | $931K | Buy |
+3,379
| New | +$931K | 0.21% | 83 |
|